Multi-Gyn has been developed by BioClin in the Netherlands . Several clinics, laboratories, and universities have contributed to the research and development of the Multi-Gyn product family for menopause symptoms. The efficacy of the MultiGyn Gel has been clinically tested by physicians and gynecologists. A study on the application of Multi-Gyn in atypical vulvitis and vaginitis (atypical = the cause is unknown), vaginal atrophy and atrophic vaginitis, showed a very high percentage of improvement from complaints. Another study concluded that the coccoid overgrowth (e.g. gardnerella) of bacterial vaginosis disappears with the application of Multi-Gyn, because of the correction of the vaginal pH and the stimulation of the growth of lactobacilli. Therefore the frequent prescription of antibiotics for vaginal problems can be avoided. Long term antibiotic treatment can cause other vagina problems due to the affected good bacteria. Vaginal smears show the excellent treatment results of Multi-Gyn for yeast infection, bacterial vaginosis, atrophic vaginitis, and vaginal atrophy.
See clinical studies here: Clinical Studies
Also, see BioClin MultiGyn clinical research at this same address.
MultiGyn technical articles include :
Technical Articles:
Multi-Gyn Gel in the Prevention and Treatment of Bacterial Vaginosis.
A pilot study to evaluate the efficacy of Multi-Gyn in the treatment of nonspecific vulvitis and atrophic vaginitis.
For over 15 years , the MultiGyn Gel and
MultiGyn Lubricare have proven to resolve menopause symptoms like vaginal dryness, irritation and pain.
The unique bioactive characteristics of MultiGyn have made these Europe ’s leading menopause product for vaginal yeast infection, bacterial vaginosis, atrophic vaginitis and vaginal atrophy.
MultiGyn Gel and MultiGyn Lubricare continues to help thousands of customers with menopause vaginal symptoms …. Because MultiGyn has proven to work.
Keep your vagina healthy during menopause and stay feminine with MultiGyn!
|